Cargando…
表皮生长因子受体基因突变非小细胞肺癌的靶向治疗及其耐药机制
Lung cancer is the sixth leading cause of death worldwide and one of the leading cause of death from malignant tumors. Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. Epidermal growth factor receptor (EGFR) gene mutation is a common mutation in NSCLC. For advanced NSCLC pa...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976207/ https://www.ncbi.nlm.nih.gov/pubmed/35340161 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.05 |